Dimensional Fund Advisors
OYST

Dimensional Fund Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Dimensional Fund Advisors’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,517
Closed -$85K – 3552
2022
Q2 		$85K Sell
19,517
-4,560
-19% -$25.9K ﹤0.01% 3348
2022
Q1 		$280K Buy
24,077
+8,035
+50% +$95.7K ﹤0.01% 3258
2021
Q4 		$293K Buy
+16,042
New +$204K ﹤0.01% 3275

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's OYST Position: Q3 2022 in Review

Dimensional Fund Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2022, closing a stake of 19,517 shares — an estimated $85K sold.

Dimensional Fund Advisors first reported a position in OYST in Q4 2021 and held it in 3 quarters. The position peaked at $293K in Q4 2021. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

  • Dimensional Fund Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 19,517 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022, an estimated $85K.
  • Dimensional Fund Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Dimensional Fund Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $293K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.